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ABSTRACT
We here investigated the effects of overexpressed superoxide dismutase (SOD)1 and amyotrophic
lateral sclerosis (ALS)-linked SOD1 mutants G93A and G147S in Neuro 2A (N2A) cell lines, and found
a three-fold increase in lamellipodia either in cells cultured under differentiated or undifferentiated
growth conditions. In undifferentiated N2A cells, SOD1 constructs promoted lamellipodial protru-
sions to similar extent as the overexpression of Rac1, and SOD1-mediated lamellipodia were
prevented by coexpression of the N17 dominant-negative form of Rac1, or shRNA for a downstream
effector of Rac1, the insulin receptor tyrosine kinase substrate p53 (IRSp53) or its binding partner
LIN7. Moreover, no additive effect was measured by coexpression of the SOD1 constructs with Rac1,
IRSp53 or LIN7. Collectively these data support a role for SOD1 in the regulation of Rac1-mediated
lamellipodia pathway, a property fully retained by the two SOD1 mutants.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a devastating age-
related neurodegenerative disease characterised by a pro-
gressive loss of motor neurons of the central nervous
system, leading to progressive muscle denervation and
paralysis [1]. No effective therapy is available for ALS,
and understanding the disease pathogenesis could help
in developing effective treatments. The majority of ALS
cases are sporadic while familial forms account only for
10% of all ALS [2]. Twenty percent of inherited ALS is
caused by mutations in the gene encoding for superoxide
dismutase 1 (SOD1), an ubiquitously expressed enzyme
functioning in the clearance of potentially toxic super-
oxide radicals. The resulting mutant proteins have addi-
tional but still unclear functions that are toxic for motor
neurons. A non-cell autonomous mechanism involving
contiguous and functionally related glial cells has also
been implicated in the disease [3]. Whereas damage to
motor neurons is associated to the onset of ALS, damage
to astrocytes and microglia severely accelerates disease
progression [4–6].
Toxicity of mutant SOD1 has been associated with
overactivation of NADPH oxidase (NOX2), due to an
apparent higher affinity of mutants to the Rac1 member
of the Rho GTPase family, compared to the wild-type
(WT) SOD1, which in turn would lock NOX2 in its
active superoxide-producing form even in oxidising con-
ditions when the WT form dissociates from Rac1 [7].
Rac1 is, however, known to play a major role in the
regulation of the actin cytoskeleton inside lamellipodia,
the actin-based membranous projections that usually
appear on moving edge of any cell type [8] and that
are fundamental for neurite formation and collateral
branches outgrowth [9]. We therefore analysed whether
SOD1 may promote lamellipodial protrusions, and
whether this property is retained by ALS-associated
mutated SOD1. The SOD1 mutants used in this study
are the well characterised G93A mutant, which is
known to retain the dismutase catalytic activity of the
WT enzyme [10], and the less studied G147S, lacking of
the catalytic activity and causing a very rapid clinical
course of the disease [11]. The effects of SOD1 over-
expression were investigated in Neuro 2A (N2A) cells, a
mouse neural crest-derived cell line that exhibit fibro-
blast-like morphology when cultured in regular med-
ium supplemented with 15% serum, while differentiate
into neuronal-like cells within a few days when cultured
in serum-deprived medium [12].
The effects of SOD1 overexpression on lamellipo-
dia formation were quantitatively analysed by phal-
loidin immunostaining to visualise the typical
F-actin staining inside lamellipodia. The SOD1-
mediated pathway for lamellipodia was investigated
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by coexpression experiments with WT or a domi-
nant negative Rac1, and by interfering with the
expression of a downstream effector of Rac1, the
insulin receptor substrate of 53 kDa, IRSp53 [8,13],
and its binding partner LIN7 [14]. In addition, to
verify the effect of SOD1 overexpression in neuronal
differentiation, the lamellipodia promoting activity
of SOD1 constructs was also investigated in N2A
cells cultured under serum-free conditions.
Results
Overexpression of SOD1 mediates Rac1-dependent
lamellipodia extension in neuronal-like N2A cells
To test whether SOD1 could induce the formation of
membrane protrusions in neuronal cells, we ectopically
overexpressed untagged WT human SOD1 or the ALS-
linked G93A and G147S mutants in N2A cells.
Approximately a 8 fold level of expression over the endo-
genous was measured for each transfected SOD1 (see
Figure S1). In addition, as negative and positive controls,
the cells were transiently transfected with GFP fused to a
plasma membrane localisation signal (mGFP) and Rac1
fused to HA, respectively. Cells cultured in undifferen-
tiated growth conditions (15% FBS) for 48 hours after
transfection were scored for the presence of lamellipodial
protrusions by phalloidin staining of F-actin.
In these culture conditions, N2A cells have either a
spherical or fibroblast-like morphology, and extend
lamellipodia and filopodia in order to sense and sample
the surrounding environment. Localisation of SOD1 as
well as Rac1 in F-actin enriched lamellipodia was
clearly revealed by indirect double immunofluorescence
staining with the specific antibodies (Figure 1(A)).
We next compared the lamellipodia-inducing capa-
city of SOD1 with that of Rac1, and analysed the effect
of their cotransfection (Figure 1(B)). Approximately a
three-fold increase in the percentage of lamellipodia-
bearing cells was found in Rac1-transfected cells
(~52%) compared to mGFP transfected cells (~17%).
The overexpression of SOD1, either WT or mutants,
promoted a similar increase in lamellipodia than Rac1
(~47%). The same effect measured in cells expressing
Rac1 alone was obtained in cells coexpressing Rac1
with each of the SOD1 constructs (~52%), suggesting
that SOD1 and Rac1 are in the same pathway.
In order to verify this possibility, Rac1 was inhibited
by expression of a dominant negative mutant, the HA-
tagged Rac1-N17 (Figure 1(B)). As expected, inhibition
of Rac1 activity decreased the number of cells with
lamellipodia under 10% in control mGFP-cells, and,
most importantly, the percentage of lamellipodia-bearing
cells remained at control levels also in SOD1-cotrans-
fected cells (~13,5%), thus suggesting that SOD1 is
unable to stimulate lamellipodia when Rac1 activity is
inhibited.
In line with data in literature indicating a main role
for Rac1 activation in the formation and function of
lamellipodia rather than filopodia, we did not detect
any increase in filopodia in cells expressing SOD1 and/
or Rac1 (data not shown).
The IRSp53-LIN7 complex is a downstream effector
of SOD1-mediated extension of lamellipodia
We next tested SOD1 involvement in Rac1–mediated
pathway for lamellipodia formation by altering the
expression of a downstream effector of Rac1, the insulin
receptor substrate protein of 53 KDa (IRSp53, also named
BAIAP2), which acts as a link between Rac1 and WAVE-
ARP 2/3 complexes in signalling lamellipodia forma-
tion [8,13].
The IRSp53 protein contains multiple domains for
protein–protein interactions, including a PDZ domain-
binding motif at its C-terminus for interaction with the
scaffold protein LIN7 (also named MALS/Velis), and
LIN7 association is required to positively regulate
IRSp53 activity at specific membrane sites in epithelial
and neuronal cells [14–17]. We therefore tested whether
IRSp53 and LIN7 play a role in SOD1-dependent for-
mation of lamellipodia by analysing the percentage of
lamellipodia-bearing cells in SOD1 overexpressing N2A
cells downregulated for/coexpressing IRSp53 or LIN7
(Figure 1(C–D)).
SOD1-mediated increase in lamellipodia was greatly
prevented in N2A cells downregulated for IRSp53 or
LIN7C, the LIN7 form mainly expressed by these
cells [16]. In line with a role for the IRSp53-LIN7 complex
in lamellipodia formation, the percentage of SOD1-
expressing cells with lamellipodia (~45%) dropped to
~21% and ~17% in cells downregulated for IRSp53 or
LIN7, respectively. Moreover, the overexpression of
IRSp53 or LIN7 promoted a > two-fold increase in the
percentage of cells with lamellipodia (from 17% to
~40%), and no further increase was observed in cells co-
expressing IRSp53 or LIN7 with any of the SOD1 con-
structs (Figure 1(D)).
Once again we did not observe a different behaviour
among SOD1 WT and the mutants, thus indicating that
these mutants retain their function in promoting
lamellipodia.
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Overexpression of SOD1 stimulates formation of
lamellipodia in N2A cells cultured under
differentiated growth conditions
In order to evaluate the effect of SOD1 expression on
membrane dynamics in differentiated N2A cells,
24 hours after transfection cells were cultured for addi-
tional 24–48 hrs in serum-deprived media (-FBS) prior
to fixation and immunofluorescence staining for
F-actin and SOD1 to analyse lamellipodial protrusions
in transfected cells (Figure 2).
Figure 1. Wild-type SOD1 and ALS-linked SOD1 G93A and G147S mutants induce Rac1-dependent extension of lamellipodia in N2A
cells cultured under undifferentiated conditions. (A) Wide-field microscopy of N2A cells transfected with the indicated cDNA. Twenty-
four hours after transfection, cells were fixed in 4% paraformaldehyde for 20 min at 37°C and stained with Rhodamine-conjugated
Phalloidin to visualise F-actin enriched lamellipodia (red), and anti-SOD1 or anti HA-tag to localise Rac1 (green). A 2X individual
staining magnification of lamellipodia is shown. Scale bar; 10 μm. (B-D) Histograms representing quantifications of the percentage of
the transfected cells exhibiting lamellipodia, 24 hours after cotransfection with the indicated cDNAs (n > 120 cells from 3
independent experiments). Error bars indicate ± s.e.m.; P-values (t-test): *P < 0.05, **P < 0.01 and ***P < 0.001 indicate significance
between mGFP and WT SOD1 or between mGFP and SOD1 mutants.
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Figure 2. Lamellipodial extension induced by the expression of wild-type SOD1 and ALS-linked SOD1mutants in N2A cells cultured under
differentiated conditions. (A-B) N2A cells transfected with the indicated cDNAs were cultured in serum depletedmedia (-FBS) for additional
24–48 hours before fixation. (A) The histograms represent the percentage of the transfected cells bearing lamellipodia (n > 120 cells from 3
independent experiments), and the mean percentage of cell perimeter occupied by lamellipodia (n = 60 cells from three independent
experiments). Error bars indicate ± s.e.m. P-values (t-test): *P < 0.05, **P < 0.01 and ***P < 0.001. (B) Representative wide-field microscopy
of N2A cells transfected with the indicated cDNAs (left), and stained with Rhodamine-conjugated Phalloidin to visualise F-actin in
lamellipodia (red), and anti-SOD1 (green). Scale bar: 10 µm.
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The quantitative analysis indicated significant higher
lamellipodia-inducing activity in N2A cells transfected
with SOD1, either WT or mutants, compared to control
mGFP transfected cells: upon serum deprivation for 24
or 48 hrs, the percentage of cells with lamellipodia
dropped to under 10% in mGFP transfected cells,
while it remained high (~40%) in SOD1-transfected
cells. Moreover, in these cells, lamellipodia occupied
one third of their entire perimeter (Figure 2(A)).
N2A cells expressing mGFP showed a morphology
typical of differentiated neuronal cells (Figure 2(B)),
characterised by few short and one longer neurite emer-
ging from the cell body, with occasional lamellipodia
restricted to their extremity (growth cone). This cell
morphology was significantly altered in SOD1 trans-
fected cells: processes of similar length were emerging
from the cell body and lamellipodia were not restricted
to their growth cones, but rather unusually found all
along neurite shafts. These alterations were virtually
never observed in mGFP expressing cells, while they were
clearly detected also in cells overexpressing all SOD1
constructs. The altered morphology observed in these
cells suggest that overstimulation of lamellipodial path-
ways might be detrimental to neuronal differentiation.
Discussion
This study is based on data in literature reporting that wild
type SOD1 and some ALS-mutated SOD1 forms bind and
stabilise theRhoGTPases Rac1 [7]. In glial cells, the authors
identified NOX2 as a target of Rac1 activity promoted by
SOD1. However, Rac1 activity is mainly involved in the
organisation of actin-based lamellipodial protrusions in all
the cell types, with pivotal roles in neurons, where these
structures are required for axon extension and guidance,
formation of axon branches and synaptic structures [9].We
therefore hypothesised that overexpression of SOD1 and
ALS-associated mutated SOD1 would promote lamellipo-
dial protrusions in neuronal cells. This hypothesis was
tested in N2A cells cultured under undifferentiated and
differentiated conditions, and in both cell culture condi-
tions we found that the expression of SOD1 promoted a
three-fold increase in lamellipodia, identified by their typi-
cal morphology of sheet-like membrane protrusions
enriched in F-actin.
The involvement of Rac1 in the SOD1 mediated
pathway for lamellipodia is inferred by results obtained
in undifferentiated N2A cells. In these cells we
found that: i) overexpressed SOD1 stimulated lamelli-
podia to similar extent than overexpressed Rac1;
ii) SOD1-mediated lamellipodia were prevented by
inhibition of Rac1 pathways (by coexpression of the
dominant negative Rac1 N17 or in cells downregulated
for a downstream effector of Rac1, the IRSp53-LIN7
complex); (iii) no further increase in lamellipodia was
observed in SOD1 cells coexpressing Rac1, IRSp53 or
LIN7.
Collectively these data support the possibility that
the increase in lamellipodia observed in the surface of
cells overexpressing SOD1 is a consequence of SOD1
activation of Rac1-mediated pathway for lamellipodial
extension. Harraz and colleagues [7] have previously
shown that wild type SOD1 and mutants L8Q and
G10V (both lacking their catalytic activity) bind and
activate Rac1, our data suggest that this also occurs for
the G93A and G147S mutants. In line with the possi-
bility that also these SOD1 mutants bind and activate
Rac1, the similar increase in lamellipodia found in cells
overexpressing G93A and G147S is not surprising.
However, reduced rather than increased levels of acti-
vated Rac1 (Rac1GTP) were found in cell lysates of SH-
SY5Y neuroblastoma cells overexpressing SOD1
mutants G93A and H80R [18]. The decrease in acti-
vated Rac1 may be due to differences in neuronal cell
type, alternatively, the lamellipodia measurement used
in our study may better reflect Rac1 activity on the cell
surface than total Rac1GTP measured by pull down
assays.
The overactivation of lamellipodial pathways was
observed either by overexpression of WT or mutated
forms of SOD1 and was associated to morphological
defects during neuronal differentiation in N2A cells,
suggesting a novel mechanism of SOD1-mediated neu-
rotoxicity. Regulatory mechanisms normally preventing
toxicity of WT SOD1 at basal expression levels might
be unable to operate in conditions of overexpression. In
line with this possibility, neuronal tissue abnormalities
have been reported in WT SOD1 transgenic mice [19],
and abnormally high levels of SOD1 transcripts were
reported in spinal cord, brain stem and lymphocytes of
sporadic ALS patients [20], although it remains to be
investigated whether these conditions are associated to
overstimulation of Rac1-mediated pathway for
lamellipodia.
Materials and methods
Constructs
The constructs GFP-IRSp53, GFP-LIN7A and shRNA
LIN7C have been previously described [15,16]; shRNA
IRSp53 was purchased from Sigma Aldrich. A 50%
reduction of LIN7 was achieved by shRNA
LIN7C [16], while a slightly lower downregulation of
IRSp53 was detected by Western blot in cells trans-
fected with shRNA IRSp53 (Figure S2). cDNAs for
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human SOD1 and SOD1G93A were a kind gift of
Dr. C. Bendotti [21]. SOD1 G147S was generated by
means of Quickchange Site-directed Mutagenesis
(Stratagene, CA) polymerase chain reaction (PCR)
using the hSOD1 cDNA as the template. The full-
length cDNA insert was excised and recloned into the
BamHI and NotI sites of the mammalian expression
vector pcDNA3 (Invitrogen, Paisley, UK). The absence
of unwanted substitution was checked by sequencing.
The GFP construct fused to a membrane localisation
sequence (mGFP) was a kind gift from Dr N. Borgese [22].
pCDNA3-Rac1-HA and pCDNA3-Rac1N17 were a kind
gift of Dr. G. Scita.
Cell culture and transfection
Murine neuroblastoma Neuro2A (N2A) cells [23] were
grown in DMEM with 10% foetal bovine serum (FBS),
1 mM glutamine and antibiotics. The cell lines were
cultured in a 37°C incubator containing 5% CO2.
Transfections: cDNAs and shRNAs were transiently
transfected in N2A cells by using PEI (Invitrogen,
Carlsbad, CA), following the manufacturer’s protocol.
To maintain the same dosage of transfected SOD1 in all
the experiments, SOD1 cDNA has been always cotrans-
fected with control empty vectors or with the cDNA of
interest. Twenty-four hours after transfection cells were
cultured for additional 24 or 48 hours in media con-
taining 15% FBS (undifferentiated N2A), or in regular
media depleted of serum (-FBS) for 24 or 48 h (differ-
entiated cells) before paraformaldehyde fixation.
Antibodies
The polyclonal rabbit anti-LIN7 antiserum was raised
against the histidine-LIN7A fusion protein [15]; the
polyclonal rabbit anti-IRSp53 was a kind gift from Dr
E. Kim (Korea Advanced Institute of Science and
Technology) [24]. Commercial primary antibodies:
sheep polyclonal against human SOD1 (Calbiochem,
Darmstadt, Germany) and mouse monoclonal anti-
HA antibody (Invitrogen, Paisley, UK).
Immunofluorescence
After being grown and transfected as described, the
cells were fixed for 20 min in 4% paraformaldehyde
in 0.1 M phosphate buffer (pH 7.4) and permeabilised
with 0.5% Triton X-100. Immunostaining with primary
antibodies was followed by incubation with Fluorescein
isothiocyanate (FITC)/CY5 anti-rabbit/mouse antibo-
dies (Jackson ImmunoResearch). Texas-red Phalloidin
was used to stain F-actin (Molecular Probes). Wide-
field microscopy was performed with a Zeiss Axioplan
inverted phase-contrast microscope (60x objective)
connected with an AxioCam HRm CCD camera.
Image and statistical analysis
For quantification of the percentage of cells–bearing
lamellipodia: The percentage was manually quantified
using a Zeiss Axioplan inverted phase-contrast micro-
scope (60× objective) connected with an AxioCam
HRm CCD camera. Lamellipodia were defined as
ruffled plasma membrane processes containing brush-
like actin filaments. This definition in no way attributes
any functional value to these structures and is purely a
reflection of morphological similarity to lamellipodia.
For each condition and transfectant, data are the mean
± s.e.m. of 150 cells examined in randomly chosen
fields from 3 independent experiments.
For quantification of the percentage of cell perimeter
occupied by lamellipodia, wide-field images of trans-
fected N2A cells were analysed with ImageJ as follows:
the full perimeter of each cell was measured with the
“segmented line” tool. Lamellipodia of the same cells
(identified by both the typical ruffled appearance of the
plasma membrane and the brush-like appearance of
F-actin) were then outlined and measured with the
same tool. For each condition and transfectant, data
are the mean ± s.e.m. of 60 cells from 3 independent
experiments.
All quantitative data are presented as means ± s.e.m.;
multiple comparisons among groups were carried out
with Student’s t-test using Prism software (GraphPad
PrismTM software).
Disclosure statement
No potential conflict of interest was reported by the authors.
ORCID
Ilaria Ferrari http://orcid.org/0000-0002-2629-0347
Chiara Verpelli http://orcid.org/0000-0003-2949-9725
Carlo Sala http://orcid.org/0000-0003-0662-9523
Diego Fornasari http://orcid.org/0000-0002-9668-3103
Grazia Pietrini http://orcid.org/0000-0002-1148-8465
References
[1] Robberecht W, Philips T. The changing scene of amyo-
trophic lateral sclerosis. Nat Rev Neurosci.
2013;14:248–264.
[2] Renton AE, Chiò A, Traynor BJ. State of play in amyo-
trophic lateral sclerosis genetics. Nature Neurosci.
2014;17:17–23.
e1486652-6 I. FERRARI ET AL.
[3] Clement AM, Nguyen MD, Roberts EA, et al. Wild-
type nonneuronal cells extend survival of SOD1
mutant motor neurons in ALS mice. Science.
2003;302:113–117.
[4] Boillée S, Yamanaka K, Lobsiger CS, et al. Onset and
progression in inherited ALS determined by motor
neurons and microglia. Science. 2006;312:1389–1392.
[5] Yamanaka K, Boillee S, Roberts EA, et al. Mutant
SOD1 in cell types other than motor neurons and
oligodendrocytes accelerates onset of disease in ALS
mice. Proc Natl Acad Sci USA. 2008;105:7594–7599.
[6] Yamanaka K, Chun SJ, Boillee S, et al. Astrocytes as
determinants of disease progression in inherited
amyotrophic lateral sclerosis. Nat Neurosci.
2008;11:251–253.
[7] Harraz MM, Marden JJ, Zhou W, et al. SOD1 muta-
tions disrupt redox-sensitive Rac regulation of NADPH
oxidase in a familial ALS model. J Clin Invest.
2008;118:659–670.
[8] Bisi S, Disanza A, Malinverno C, et al. Membrane and
actin dynamics interplay at lamellipodia leading edge.
Curr Opin Cell Biol. 2013;25:565–573.
[9] da Silva JS, Dotti CG. Breaking the neuronal sphere:
regulation of the actin cytoskeleton in neuritogenesis.
Nat Rev Neurosci. 2002;3:694–704.
[10] Valentine JS, Hart PJ. Misfolded CuZnSOD and amyo-
trophic lateral sclerosis. Proc Natl Acad Sci USA.
2003;100:3617–3622.
[11] Origone P, Caponnetto C, Mantero V, et al. Fast course
ALS presenting with vocal cord paralysis: clinical fea-
tures, bioinformatic and modelling analysis of the
novel SOD1 Gly147Ser mutation. Amyotroph Lateral
Scler. 2012;13:144–148.
[12] Wu G, Fang Y, Lu ZH, et al. Induction of axon-like
and dendrite-like processes in neuroblastoma cells. J
Neurocytol. 1998;27:1–14.
[13] Miki H, Yamaguchi H, Suetsugu S, et al. IRSp53 is an
essential intermediate between Rac and WAVE in
the regulation of membrane ruffling. Nature.
2000;6813:732–735.
[14] Hori K, Konno D, Maruoka H, et al. MALS is a bind-
ing partner of IRSp53 at cell-cell contacts. FEBS Lett.
2003;554:30–34.
[15] Massari S, Perego C, Padovano V, et al. LIN7 mediates
the recruitment of IRSp53 to tight junctions. Traffic.
2009;10:246–257.
[16] Crespi A, Ferrari I, Lonati P, et al. LIN7 regulates the
filopodium- and neurite-promoting activity of IRSp53.
J Cell Sci. 2012;125:4543–4554.
[17] Ferrari I, Crespi A, Fornasari D, et al. Novel localisa-
tion and possible function of LIN7 and IRSp53 in
mitochondria of HeLa cells. Eur J Cell Biol.
2016;95:285–293.
[18] Pesaresi MG, Amori I, Giorgi C, et al. Mitochondrial
redox signalling by p66Shc mediates ALS-like disease
through Rac1 inactivation. Hum Mol Genet.
2011;20:4196–4208.
[19] Afshar P, Ashtari N, Jiao X, et al. Overexpression of
human SOD1 leads to discrete defects in the cerebellar
architecture in the mouse. Front Neuroanat.
2017;11:22.
[20] Gagliardi S, Cova E, Davin A, et al. SOD1 mRNA
expression in sporadic amyotrophic lateral sclerosis.
Neurobiol Dis. 2010;39:198–203.
[21] Tortarolo M, Crossthwaite AJ, Conforti L, et al.
Expression of SOD1 G93A or wild-type SOD1 in pri-
mary cultures of astrocytes down-regulates the gluta-
mate transporter GLT-1: lack of involvement of
oxidative stress. J Neurochem. 2004;88:481–493.
[22] Ronchi P, Colombo S, Francolini M, et al.
Transmembrane domain-dependent partitioning of
membrane proteins within the endoplasmic reticulum.
J Cell Biol. 2008;181:105–118.
[23] Klebe RJ, Ruddle FH. Neuroblastoma: cell culture ana-
lysis of a differentiating stem cell system. J Cell Biol.
1969;43:69a.
[24] Choi J, Ko J, Racz B, et al. Regulation of dendritic spine
morphogenesis by insulin receptor substrate 53, a
downstream effector of Rac1 and Cdc42 small
GTPases. J Neurosci. 2005;25:869–879.
COMMUNICATIVE & INTEGRATIVE BIOLOGY e1486652-7
